• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血再灌注损伤导致的心脏功能障碍中外源和内源蛋白酶。

Extracellular and intracellular proteases in cardiac dysfunction due to ischemia-reperfusion injury.

机构信息

Institute of Cardiovascular Sciences, St Boniface Hospital Research Centre, and Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

出版信息

Int J Cardiol. 2013 Mar 20;164(1):39-47. doi: 10.1016/j.ijcard.2012.01.103. Epub 2012 Feb 20.

DOI:10.1016/j.ijcard.2012.01.103
PMID:22357424
Abstract

Various procedures such as angioplasty, thrombolytic therapy, coronary bypass surgery, and cardiac transplantation are invariably associated with ischemia-reperfusion (I/R) injury. Impaired recovery of cardiac function due to I/R injury is considered to be a consequence of the occurrence of both oxidative stress and intracellular Ca(2+)-overload in the myocardium. These changes in the ischemic myocardium appear to activate both extracellular and intracellular proteases which are responsible for the cleavage of extracellular matrix and subcellular structures involved in the maintenance of cardiac function. It is thus intended to discuss the actions of I/R injury on several proteases, with a focus on calpain, matrix metalloproteinases, and cathepsins as well as their role in inducing alterations both inside and outside the cardiomyocytes. In addition, modifications of subcellular organelles such as myofibrils, sarcoplasmic reticulum and sarcolemma as well as extracellular matrix, and the potential regulatory effects of endogenous inhibitors on protease activities are identified. Both extracellular and intracellular proteolytic activities appear to be imperative in determining the true extent of I/R injury and their inhibition seems to be of critical importance for improving the recovery of cardiac function. Thus, both extracellular and intracellular proteases may serve as potential targets for the development of cardioprotective interventions for reducing damage to the heart and retarding the development of contractile dysfunction caused by I/R injury.

摘要

各种程序,如血管成形术、溶栓治疗、冠状动脉旁路手术和心脏移植,都不可避免地与缺血再灌注(I/R)损伤有关。由于 I/R 损伤导致的心脏功能恢复受损被认为是心肌中氧化应激和细胞内 Ca(2+)-超载同时发生的结果。缺血心肌中的这些变化似乎激活了细胞外和细胞内的蛋白酶,这些蛋白酶负责切割细胞外基质和参与维持心脏功能的亚细胞结构。因此,本文旨在讨论 I/R 损伤对几种蛋白酶的作用,重点讨论钙蛋白酶、基质金属蛋白酶和组织蛋白酶,以及它们在诱导心肌细胞内外变化中的作用。此外,还确定了亚细胞器(如肌原纤维、肌浆网和肌膜)以及细胞外基质的改变,以及内源性抑制剂对蛋白酶活性的潜在调节作用。细胞外和细胞内的蛋白水解活性似乎对确定 I/R 损伤的真实程度至关重要,抑制它们对于改善心脏功能的恢复似乎至关重要。因此,细胞外和细胞内的蛋白酶都可以作为开发心脏保护干预措施的潜在靶点,以减少心脏损伤并延缓由 I/R 损伤引起的收缩功能障碍的发展。

相似文献

1
Extracellular and intracellular proteases in cardiac dysfunction due to ischemia-reperfusion injury.缺血再灌注损伤导致的心脏功能障碍中外源和内源蛋白酶。
Int J Cardiol. 2013 Mar 20;164(1):39-47. doi: 10.1016/j.ijcard.2012.01.103. Epub 2012 Feb 20.
2
Activation of proteolytic enzymes and depression of the sarcolemmal Na+/K+-ATPase in ischemia-reperfused heart may be mediated through oxidative stress.缺血再灌注心脏中蛋白水解酶的激活和肌浆网 Na+/K+-ATP 酶的抑制可能是通过氧化应激介导的。
Can J Physiol Pharmacol. 2012 Feb;90(2):249-60. doi: 10.1139/y11-128. Epub 2012 Feb 8.
3
Potential role and mechanisms of subcellular remodeling in cardiac dysfunction due to ischemic heart disease.亚细胞重塑在缺血性心脏病所致心脏功能障碍中的潜在作用及机制
J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):238-50. doi: 10.2459/01.JCM.0000263489.13479.68.
4
The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart.肌浆网蛋白是缺血再灌注心脏中钙蛋白酶作用的靶点。
J Mol Cell Cardiol. 2004 Jul;37(1):101-10. doi: 10.1016/j.yjmcc.2004.04.009.
5
Role of proteases in the pathophysiology of cardiac disease.蛋白酶在心脏疾病病理生理学中的作用。
Mol Cell Biochem. 2004 Aug;263(1-2):241-56.
6
Modification of Ischemia/Reperfusion-Induced Alterations in Subcellular Organelles by Ischemic Preconditioning.缺血预处理对缺血/再灌注诱导的亚细胞器官改变的修饰作用。
Int J Mol Sci. 2022 Mar 22;23(7):3425. doi: 10.3390/ijms23073425.
7
Calpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion.钙蛋白酶易位和激活作为心肌缺血/再灌注期间的药理学靶点。
J Mol Cell Cardiol. 2010 Aug;49(2):271-9. doi: 10.1016/j.yjmcc.2010.02.024. Epub 2010 Mar 6.
8
Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart.缺血再灌注损伤会激活人类心脏中的基质金属蛋白酶。
Eur Heart J. 2005 Jan;26(1):27-35. doi: 10.1093/eurheartj/ehi007. Epub 2004 Nov 30.
9
Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix.基质金属蛋白酶-2 与心肌氧化应激损伤:超越基质。
Cardiovasc Res. 2010 Feb 1;85(3):413-23. doi: 10.1093/cvr/cvp268. Epub 2009 Aug 4.
10
Role of Oxidative Stress in Cardiac Dysfunction and Subcellular Defects Due to Ischemia-Reperfusion Injury.氧化应激在缺血再灌注损伤所致心脏功能障碍和亚细胞缺陷中的作用
Biomedicines. 2022 Jun 22;10(7):1473. doi: 10.3390/biomedicines10071473.

引用本文的文献

1
The role of sirtuins in the regulation of reactive oxygen species in myocardial ischemia/reperfusion injury.沉默调节蛋白在心肌缺血/再灌注损伤中对活性氧的调控作用。
Mol Cell Biochem. 2025 Jun;480(6):3501-3520. doi: 10.1007/s11010-024-05204-9. Epub 2025 Feb 7.
2
N-Terminomic Identification of Intracellular MMP-2 Substrates in Cardiac Tissue.N-端肽组学鉴定心肌组织细胞内 MMP-2 的底物。
J Proteome Res. 2024 Oct 4;23(10):4188-4202. doi: 10.1021/acs.jproteome.3c00755. Epub 2024 Apr 22.
3
The roles of intracellular proteolysis in cardiac ischemia-reperfusion injury.
细胞内蛋白水解在心肌缺血再灌注损伤中的作用。
Basic Res Cardiol. 2023 Sep 28;118(1):38. doi: 10.1007/s00395-023-01007-z.
4
Role of Oxidative Stress in Cardiac Dysfunction and Subcellular Defects Due to Ischemia-Reperfusion Injury.氧化应激在缺血再灌注损伤所致心脏功能障碍和亚细胞缺陷中的作用
Biomedicines. 2022 Jun 22;10(7):1473. doi: 10.3390/biomedicines10071473.
5
Ginsenoside Rb2: A review of pharmacokinetics and pharmacological effects.人参皂苷Rb2:药代动力学与药理作用综述
J Ginseng Res. 2022 Mar;46(2):206-213. doi: 10.1016/j.jgr.2021.11.007. Epub 2021 Nov 19.
6
Modification of Ischemia/Reperfusion-Induced Alterations in Subcellular Organelles by Ischemic Preconditioning.缺血预处理对缺血/再灌注诱导的亚细胞器官改变的修饰作用。
Int J Mol Sci. 2022 Mar 22;23(7):3425. doi: 10.3390/ijms23073425.
7
Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury.重组人分泌型白细胞蛋白酶抑制剂(rhSLPI)的缺血后治疗减轻了心肌缺血/再灌注损伤。
Biomedicines. 2021 Apr 13;9(4):422. doi: 10.3390/biomedicines9040422.
8
Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.补体因子B的激活会导致小鼠和人类心肌缺血/再灌注损伤。
PLoS One. 2017 Jun 29;12(6):e0179450. doi: 10.1371/journal.pone.0179450. eCollection 2017.
9
The Human Ether-a-go-go-related Gene (hERG) Potassium Channel Represents an Unusual Target for Protease-mediated Damage.人类醚-去极化相关基因(hERG)钾通道是蛋白酶介导损伤的一个特殊靶点。
J Biol Chem. 2016 Sep 23;291(39):20387-401. doi: 10.1074/jbc.M116.743138. Epub 2016 Aug 8.
10
Berberine Attenuates Myocardial Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation Response: Role of Silent Information Regulator 1.黄连素通过减轻氧化应激和炎症反应减轻心肌缺血/再灌注损伤:沉默信息调节因子1的作用
Oxid Med Cell Longev. 2016;2016:1689602. doi: 10.1155/2016/1689602. Epub 2015 Dec 14.